# Genaxis

Genaxis is a Private Equity based in Seocho-gu, Seoul, South Korea.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Seocho-gu, Seoul, South Korea
- **Region:** Asia
- **Address:** 311 Gangnam-daero, 717ho (DreamPlus, Gangnam), Seocho-gu, Seoul, South Korea
- **Founded:** 2019
- **Assets under management:** Undisclosed
- **Website:** genaxis.co.kr
- **LinkedIn:** linkedin.com/company/젠엑시스

## Regulatory record

- **Reports private funds:** No

## About

Genaxis is a global accelerator that invests in startups from the seed stage to growth. The company is based in Seoul, South Korea, and its address is 311, Gangnam-daero, Seocho-gu. Genaxis contributes to the development of Korea's core growth industries by investing in promising startups.

## Sectors

- Biotech
- Healthcare Services

## People

- Mikyeong Son — CEO

## Questions

### Who runs investment decisions at Genaxis?

CEO Mikyeong Son runs the investment committee. She is also listed as the personal-information manager on the firm’s website, which is common in lean Korean Registered Accelerators where the managing director retains final sign-off on every term sheet. The firm does not name any additional investment partners or venture partners in its public materials.

### Is Genaxis a traditional venture fund or an accelerator?

It operates as an accelerator, not a blind-pool venture fund. Genaxis is structured as a private individual investment association that mentors startups before and after seed rounds. The firm maintains two portfolio buckets — an incubation track for pre-revenue teams and an investment track for companies that have reached the start-up stage. Both tracks focus exclusively on biotechnology and healthcare services.

### What investment stages does Genaxis target?

Seed and start-up rounds only. The firm’s own materials state it invests at the earliest stages and then supports companies through education programs, regulatory guidance, and global scale-up partnerships. It does not participate in Series B or later-stage rounds based on its disclosure.

### Which sectors does Genaxis explicitly avoid?

Everything outside biotechnology and healthcare services. Genaxis’s website, portfolio, and incubation rosters show no exposure to software, deep-tech hardware, consumer internet, or any other sector. The firm’s self-description as a bio-specialist is a binding constraint, not a preference.

## Related profiles

- [GenAI Fund](https://altss.com/profile/genai-fund)
- [Genblock Capital](https://altss.com/profile/genblock-capital)

---

Last updated: 2026-07-11T00:31:40.000Z

Canonical page: https://altss.com/profile/genaxis

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology